TLR4 and Parkinson disease: A similar disruption of the expected PD pathophysiology was seen following the use of TLR4 antagonists and TLR4 blocking antibodies, and when the vagus nerve was cut suggesting that this is the likely route by which α-synuclein spreads, prion-like, to the brain (Kim et al., 2019).